The Immune System as Anti-Cancer Therapy is organized by Baptist Health South Florida and will be held from Feb 01, 2018 - Feb 01, 2020.
The target audience for this medical event is Pediatricians, Pediatric Oncologists, Hematologists/Oncologists, Infectious Disease Pediatricians, Pediatric General Internists, Family Physicians, Neonatologists, Respiratory Therapists, Pharmacists and Emergency Department Physicians. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Course Description :
This course will discuss the biology, rationale and preclinical development of chimeric antigen receptor (CAR) modified T cells as an anti-cancer therapy, current results and future applications in cancer immunotherapy.
Learning Objectives :
• Explain the biology, rationale and preclinical development of chimeric antigen receptor (CAR) T cells.
• Assess the current results using CAR T cells for relapsed/refractory B-ALL.
• Describe the future application of CAR T cells in cancer immunotherapy.
Additional details will be posted as soon as they are available.